CL2A-SN-38
CL2A-SN38 is a SN38 derivative with a peptide-linker which can easily react with antibody to form an antibody-drug conjugate (ADC). CL2A-SN-38 is composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid tumor types.
| Trivial name | / |
| Catalog Number | CSN25575 |
| Alternative Name(s) | / |
| Research Area | Cancer |
| Molecular Formula | C73H97N11O22 |
| CAS# | 1279680-68-0 |
| Purity | ≥98% |
| SMILES | O=C(C=C1)N(CC2CCC(C(NCC3=CN(CCOCCOCCOCCOCCOCCOCCOCCOCCNC(COCC(N[C@H](C(NC4=CC=C(COC(O[C@]5(CC)C(OCC6=C5C=C7N(CC8=C(CC)C9=CC(O)=CC=C9N=C87)C6=O)=O)=O)C=C4)=O)CCCCN)=O)=O)N=N3)=O)CC2)C1=O |
| Size | 10mg |
| Supplier Page | https://www.csnpharm.com/products/cl2a-sn-38.html |